134 related articles for article (PubMed ID: 1391958)
1. Antiplatelet drugs and generation of thrombin in clotting blood.
Szczeklik A; Krzanowski M; Góra P; Radwan J
Blood; 1992 Oct; 80(8):2006-11. PubMed ID: 1391958
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.
Szczeklik A; Musiał J; Undas A; Gajewski P; Góra P; Swadźba J; Jankowski M
J Am Coll Cardiol; 1999 Apr; 33(5):1286-93. PubMed ID: 10193729
[TBL] [Abstract][Full Text] [Related]
3. Effects of thromboxane A2 synthase inhibitors (CV-4151 and ozagrel), aspirin, and ticlopidine on the thrombosis caused by endothelial cell injury.
Terashita Z; Imura Y; Kawamura M; Kato K; Nishikawa K
Thromb Res; 1995 Mar; 77(5):411-21. PubMed ID: 7778056
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin.
Kyrle PA; Westwick J; Scully MF; Kakkar VV; Lewis GP
Thromb Haemost; 1987 Feb; 57(1):62-6. PubMed ID: 2954260
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulation at the site of microvascular injury: effects of low-dose aspirin.
Undas A; Brummel K; Musial J; Mann KG; Szczeklik A
Blood; 2001 Oct; 98(8):2423-31. PubMed ID: 11588039
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet agents in tissue factor-induced blood coagulation.
Butenas S; Cawthern KM; van't Veer C; DiLorenzo ME; Lock JB; Mann KG
Blood; 2001 Apr; 97(8):2314-22. PubMed ID: 11290593
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia.
Szczeklik A; Musial J; Undas A; Swadzba J; Gora PF; Piwowarska W; Duplaga M
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):948-54. PubMed ID: 8696958
[TBL] [Abstract][Full Text] [Related]
9. Delayed generation of thrombin in clotting blood of atopic patients with hayfever and asthma.
Szczeklik A; Schmitz-Schumann M; Krzanowski M; Virchow C
Clin Exp Allergy; 1991 Jul; 21(4):411-5. PubMed ID: 1913263
[TBL] [Abstract][Full Text] [Related]
10. Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies.
Perzborn E; Heitmeier S; Laux V
J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):554-62. PubMed ID: 25848131
[TBL] [Abstract][Full Text] [Related]
11. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
[TBL] [Abstract][Full Text] [Related]
12. Influence of low- and high-dose aspirin treatment on thrombin generation in whole blood.
Wallén NH; Ladjevardi M
Thromb Res; 1998 Nov; 92(4):189-94. PubMed ID: 9840028
[TBL] [Abstract][Full Text] [Related]
13. Thrombinogenesis and its pharmacological modulation in atherosclerosis.
Szczeklik A; Musiał J; Dropiński J; Krzanowski M; Królikowski W; Undas A; Swadźba J; Duplaga M; Bodzoń W
J Physiol Pharmacol; 1994 Mar; 45(1):3-11. PubMed ID: 8043909
[TBL] [Abstract][Full Text] [Related]
14. Prolonged activation of prothrombin on the vascular wall after arterial injury.
Ghigliotti G; Waissbluth AR; Speidel C; Abendschein DR; Eisenberg PR
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):250-7. PubMed ID: 9484990
[TBL] [Abstract][Full Text] [Related]
15. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
[TBL] [Abstract][Full Text] [Related]
17. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
Badr Eslam R; Lang IM; Kaider A; Panzer S
Transl Res; 2013 May; 161(5):414-20. PubMed ID: 23313628
[TBL] [Abstract][Full Text] [Related]
18. Effects of antiplatelet agents on platelet-induced thrombin generation.
Wegert W; Graff J; Kaiser D; Breddin HK; Klinkhardt U; Harder S
Int J Clin Pharmacol Ther; 2002 Apr; 40(4):135-41. PubMed ID: 11996207
[TBL] [Abstract][Full Text] [Related]
19. Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury.
Undas A; Brummel K; Musial J; Mann KG; Szczeklik A
Circulation; 2001 Nov; 104(22):2666-72. PubMed ID: 11723016
[TBL] [Abstract][Full Text] [Related]
20. On the coagulation of platelet-rich plasma. Physiological mechanism and pharmacological consequences.
Béguin S; Keularts I
Haemostasis; 1999 Sep; 29(1):50-7. PubMed ID: 10494034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
